Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More

被引:90
|
作者
Saha, Abinit [1 ]
Sharma, Ashish Ranjan [2 ]
Bhattacharya, Manojit [3 ]
Sharma, Garima [4 ]
Lee, Sang-Soo [2 ]
Chakraborty, Chiranjib [1 ]
机构
[1] Adamas Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Barasat Barrackpore Rd, Kolkata 700126, W Bengal, India
[2] Hallym Univ, Chuncheon Sacred Heart Hosp, Inst Skeletal Aging & Orthoped Surg, Chuncheon Si, Gangwon Do, South Korea
[3] Fakir Mohan Univ, Dept Zool, VyasaVihar, Balasore, Odisha, India
[4] Kangwon Natl Univ, Neuropsychopharmacol & Toxicol Program, Coll Pharm, Gangwon Do, South Korea
基金
新加坡国家研究基金会;
关键词
SARS-CoV-2; Remdesivir; COVID-19; Therapeutic molecule; GS-5734; EBOLA;
D O I
10.1016/j.arcmed.2020.05.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
COVID-19 is now pandemic throughout the world. Scientist, doctors are searching for effective therapy of this diseases. The remdesivir, an antiviral drug, is appeared as 'molecule of hope' for the treatment of this disease. USFDA gave emergency approval to this drug for the treatment of COVID-19. The molecular mechanism is unknown. In this pa per, we tried to describe the probable molecular mechanism of remdesivir to inhibit the RNA synthesis of SARS-CoV-2. However, more detail mechanism is needed to understand mechanism of action of remdesivir. (c) 2020 IMSS. Published by Elsevier Inc.
引用
收藏
页码:585 / 586
页数:2
相关论文
共 50 条
  • [1] On the molecular structure of Remdesivir for the treatment of Covid-19
    Sheikholeslami, S. M.
    Jahanbani, A.
    Shao, Z.
    [J]. COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 2021, 24 (09) : 995 - 1002
  • [2] Remdesivir for the treatment of COVID-19
    Grundeis, Felicitas
    Ansems, Kelly
    Dahms, Karolina
    Thieme, Volker
    Metzendorf, Maria-Inti
    Skoetz, Nicole
    Benstoem, Carina
    Mikolajewska, Agata
    Griesel, Mirko
    Fichtner, Falk
    Stegemann, Miriam
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (01):
  • [3] Remdesivir for the treatment of COVID-19
    Ansems, Kelly
    Grundeis, Felicitas
    Dahms, Karolina
    Mikolajewska, Agata
    Thieme, Volker
    Piechotta, Vanessa
    Metzendorf, Maria-Inti
    Stegemann, Miriam
    Benstoem, Carina
    Fichtner, Falk
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (08):
  • [4] Remdesivir for the Treatment of COVID-19
    Allen, Robert
    Turner, Matthew
    DeSouza, Ian S.
    [J]. AMERICAN FAMILY PHYSICIAN, 2022, 105 (02) : 131 - 132
  • [5] REMDESIVIR IN THE TREATMENT OF COVID-19
    Rosenberg, Karen
    [J]. AMERICAN JOURNAL OF NURSING, 2021, 121 (01) : 55 - 55
  • [6] Chloroquine/hydroxycloroquine and COVID-19: need to know more about
    Cassone, Antonio
    Iacoviello, Licia
    Cauda, Roberto
    [J]. FUTURE MICROBIOLOGY, 2020, 15 (16) : 1523 - 1526
  • [7] The place for remdesivir in COVID-19 treatment
    Young, Barnaby
    Tan, Thuan Tong
    Leo, Yee Sin
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (01): : 20 - 21
  • [8] Remdesivir for the treatment of COVID-19 in pregnancy
    Lampejo, Temi
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4114 - 4119
  • [9] Inhaled remdesivir treatment for COVID-19
    Yang, C.
    Zhag, H.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2021, 25 (10) : 788 - 790
  • [10] Remdesivir for the treatment of COVID-19: a Cochrane review
    Ansems, Kelly
    Grundeis, Felicitas
    Dahms, Karolina
    Mikolajewska, Agata
    Thieme, Volker
    Piechotta, Vanessa
    Metzendorf, Maria-Inti
    Stegemann, Miriam
    Benstoem, Carina
    Fichtner, Falk
    [J]. EMERGENCIAS, 2023, 35 (06): : 465 - 467